1. Home
  2. OXLCO vs JSPRW Comparison

OXLCO vs JSPRW Comparison

Compare OXLCO & JSPRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OXLCO
  • JSPRW
  • Stock Information
  • Founded
  • OXLCO N/A
  • JSPRW N/A
  • Country
  • OXLCO United States
  • JSPRW United States
  • Employees
  • OXLCO N/A
  • JSPRW 45
  • Industry
  • OXLCO Investment Managers
  • JSPRW Biotechnology: Pharmaceutical Preparations
  • Sector
  • OXLCO Finance
  • JSPRW Health Care
  • Exchange
  • OXLCO Nasdaq
  • JSPRW Nasdaq
  • Market Cap
  • OXLCO N/A
  • JSPRW N/A
  • IPO Year
  • OXLCO N/A
  • JSPRW 2020
  • Fundamental
  • Price
  • OXLCO $23.05
  • JSPRW $0.16
  • Analyst Decision
  • OXLCO
  • JSPRW
  • Analyst Count
  • OXLCO 0
  • JSPRW 0
  • Target Price
  • OXLCO N/A
  • JSPRW N/A
  • AVG Volume (30 Days)
  • OXLCO N/A
  • JSPRW N/A
  • Earning Date
  • OXLCO N/A
  • JSPRW N/A
  • Dividend Yield
  • OXLCO N/A
  • JSPRW N/A
  • EPS Growth
  • OXLCO N/A
  • JSPRW N/A
  • EPS
  • OXLCO N/A
  • JSPRW N/A
  • Revenue
  • OXLCO N/A
  • JSPRW N/A
  • Revenue This Year
  • OXLCO N/A
  • JSPRW N/A
  • Revenue Next Year
  • OXLCO N/A
  • JSPRW N/A
  • P/E Ratio
  • OXLCO N/A
  • JSPRW N/A
  • Revenue Growth
  • OXLCO N/A
  • JSPRW N/A
  • 52 Week Low
  • OXLCO N/A
  • JSPRW N/A
  • 52 Week High
  • OXLCO N/A
  • JSPRW N/A
  • Technical
  • Relative Strength Index (RSI)
  • OXLCO 59.90
  • JSPRW N/A
  • Support Level
  • OXLCO $22.97
  • JSPRW N/A
  • Resistance Level
  • OXLCO $23.10
  • JSPRW N/A
  • Average True Range (ATR)
  • OXLCO 0.05
  • JSPRW 0.00
  • MACD
  • OXLCO 0.01
  • JSPRW 0.00
  • Stochastic Oscillator
  • OXLCO 88.09
  • JSPRW 0.00

About OXLCO Oxford Lane Capital Corp. Preferred Stock Shares 6.00% Series 2029

Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.

About JSPRW Japer Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: